Simplex Trading
NRXP icon

Simplex Trading’s NRX Pharmaceuticals NRXP Stock Holding History

Simplex Trading’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-690
Closed -$1.98K – 9730
2025
Q2 		$2K Buy
690
+57
+9% +$143 ﹤0.01% 8170
2025
Q1 		$1K Sell
633
-368
-37% -$1.04K ﹤0.01% 8263
2024
Q4 		$2K Buy
+1,001
New +$1.35K ﹤0.01% 8048
2024
Q2 		– Sell
-20
Closed -$71 – 9493
2024
Q1 		$0 Buy
+20
New +$92 ﹤0.01% 9537
2022
Q4 		– Sell
-1,423
Closed -$14.3K – 10009
2022
Q3 		$10K Buy
1,423
+1,367
+2,441% +$9.21K ﹤0.01% 8252
2022
Q2 		$0 Sell
56
-1,716
-97% -$22.5K ﹤0.01% 10713
2022
Q1 		$43K Buy
1,772
+615
+53% +$20K ﹤0.01% 7347
2021
Q4 		$55K Buy
+1,157
New +$83.5K ﹤0.01% 7135

Other funds holding NRXP

BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BFG
Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Simplex Trading's NRXP Position: Q3 2025 in Review

Simplex Trading sold out of NRX Pharmaceuticals (NRXP) in Q3 2025, closing a stake of 690 shares — an estimated $1.98K sold.

Simplex Trading first reported a position in NRXP in Q4 2021 and held it in 8 quarters. The position peaked at $55K in Q4 2021. 24 funds tracked by Wall St. Rank hold NRXP as of Q3 2025.

  • Simplex Trading reported no remaining NRX Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 690 NRX Pharmaceuticals shares in Q3 2025, an estimated $1.98K.
  • Simplex Trading first reported a position in NRX Pharmaceuticals in Q4 2021 and held it in 8 quarters.
  • Simplex Trading's NRX Pharmaceuticals position peaked at $55K in Q4 2021.
  • 24 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.